{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T02:43:03Z","timestamp":1787884983092,"version":"build-2784847793"},"reference-count":146,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T00:00:00Z","timestamp":1631059200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.apsb.2021.09.006","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T11:17:33Z","timestamp":1631272653000},"page":"532-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions"],"prefix":"10.1016","volume":"12","author":[{"given":"Leilei","family":"Fu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenke","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingjuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqi","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3900-9486","authenticated-orcid":false,"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.09.006_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2991\/jegh.k.191008.001","article-title":"Current cancer epidemiology","volume":"9","author":"Mattiuzzi","year":"2019","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/j.apsb.2021.09.006_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.apsb.2021.09.006_bib3","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jamainternmed.2017.3601","article-title":"Research and development spending to bring a single cancer drug to market and revenues after approval","volume":"177","author":"Prasad","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.apsb.2021.09.006_bib4","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.semcancer.2020.03.011","article-title":"Drug rechanneling: a novel paradigm for cancer treatment","volume":"68","author":"Kaushik","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.semcancer.2019.09.012","article-title":"Drug repurposing for breast cancer therapy: old weapon for new battle","volume":"68","author":"Aggarwal","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.canlet.2018.04.039","article-title":"Repurposing drugs for glioblastoma: from bench to bedside","volume":"428","author":"Basso","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2021.09.006_bib7","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1182\/blood-2019-01-894980","article-title":"Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNet","volume":"133","author":"Sanz","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2021.09.006_bib8","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1182\/blood-2016-09-736686","article-title":"Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab","volume":"129","author":"Abaza","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2021.09.006_bib9","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1016\/S2352-3026(18)30154-6","article-title":"Thalidomide for myeloma: still here?.","volume":"5","author":"Dimopoulos","year":"2018","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.apsb.2021.09.006_bib10","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-18-0420","article-title":"Metformin inhibits prostate cancer progression by targeting tumor-associated inflammatory infiltration","volume":"24","author":"Liu","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib11","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1007\/s13238-020-00760-4","article-title":"Metformin inhibits pancreatic cancer metastasis caused by SMAD4 deficiency and consequent HNF4G upregulation","volume":"12","author":"Wang","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.apsb.2021.09.006_bib12","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.tem.2013.05.004","article-title":"Repositioning metformin for cancer prevention and treatment","volume":"24","author":"Quinn","year":"2013","journal-title":"Trends Endocrinol Metabol"},{"key":"10.1016\/j.apsb.2021.09.006_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nm.4306","article-title":"The drug repurposing hub: a next-generation drug library and information resource","volume":"23","author":"Corsello","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2021.09.006_bib14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.semcancer.2019.12.011","article-title":"Machine and deep learning approaches for cancer drug repurposing","volume":"68","author":"Issa","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2021.09.006_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib17","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1073\/pnas.1818357116","article-title":"Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma","volume":"116","author":"Zhao","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.09.006_bib18","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1038\/ncomms3516","article-title":"Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels","volume":"4","author":"Chauhan","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.09.006_bib19","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/annonc\/mdw060","article-title":"Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer","volume":"27","author":"Jones","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.apsb.2021.09.006_bib20","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/cncr.33391","article-title":"Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K\/AKT signaling in nasopharyngeal carcinoma","volume":"127","author":"Lin","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2019-000487","article-title":"Immunomodulatory effects of renin\u2013angiotensin system inhibitors on T lymphocytes in mice with colorectal liver metastases","volume":"8","author":"Vallejo Ardila","year":"2020","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib22","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41419-020-2675-x","article-title":"Enalapril overcomes chemoresistance and potentiates antitumor efficacy of 5-FU in colorectal cancer by suppressing proliferation, angiogenesis, and NF-\u03baB\/STAT3-regulated proteins","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.09.006_bib23","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1136\/gut.2009.188961","article-title":"The angiotensin-I-converting enzyme inhibitor enalapril and aspirin delay progression of pancreatic intraepithelial neoplasia and cancer formation in a genetically engineered mouse model of pancreatic cancer","volume":"59","author":"Fendrich","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2021.09.006_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3892\/ijo.2016.3512","article-title":"Verapamil inhibits tumor progression of chemotherapy-resistant pancreatic cancer side population cells","volume":"49","author":"Zhao","year":"2016","journal-title":"Int J Oncol"},{"key":"10.1016\/j.apsb.2021.09.006_bib25","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.biopha.2016.07.031","article-title":"Fluvastatin combined with benazepril may contribute to the favorable prognosis of patients with atrial fibrillation","volume":"83","author":"Yao","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2021.09.006_bib26","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejca.2021.01.029","article-title":"Carvedilol blocks neural regulation of breast cancer progression in vivo and is associated with reduced breast cancer mortality in patients","volume":"147","author":"Gillis","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib27","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pan.2016.03.005","article-title":"Chronic stress increases experimental pancreatic cancer growth, reduces survival and can be antagonised by beta-adrenergic receptor blockade","volume":"16","author":"Partecke","year":"2016","journal-title":"Pancreatology"},{"key":"10.1016\/j.apsb.2021.09.006_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.2908","article-title":"Propranolol for off-label treatment of patients with melanoma: results from a cohort study","volume":"4","author":"De Giorgi","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.apsb.2021.09.006_bib29","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43026","article-title":"R-Propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangioma","volume":"8","author":"Overman","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.apsb.2021.09.006_bib30","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.drudis.2019.03.010","article-title":"Can cardiovascular drugs support cancer treatment? The rationale for drug repurposing","volume":"24","author":"Regulska","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2021.09.006_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1158\/2159-8274.CD-10-0020","article-title":"A novel two-stage, transdisciplinary study identifies digoxin as a possible drug for prostate cancer treatment","volume":"1","author":"Platz","year":"2011","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2021.09.006_bib32","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3390\/cancers12082169","article-title":"Identification of cardiac glycosides as novel inhibitors of eIF4A1-mediated translation in triple-negative breast cancer cells","volume":"12","author":"Howard","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2021.09.006_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.ejmech.2018.09.019","article-title":"A cardiac glycoside HTF-1 isolated from Helleborus thibetanus Franch displays potent in\u00a0vitro anti-cancer activity via caspase-9, MAPK and PI3K-Akt-mTOR pathways","volume":"158","author":"Ma","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.006_bib34","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1002\/mc.23096","article-title":"Cardiac glycoside sensitized hepatocellular carcinoma cells to TRAIL via ROS generation, p38MAPK, mitochondrial transition, and autophagy mediation","volume":"58","author":"Rasheduzzaman","year":"2019","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.apsb.2021.09.006_bib35","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.phrs.2014.06.013","article-title":"Novel prospects of statins as therapeutic agents in cancer","volume":"88","author":"Pisanti","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib36","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1073\/pnas.1917938117","article-title":"Statin-induced GGPP depletion blocks macropinocytosis and starves cells with oncogenic defects","volume":"117","author":"Jiao","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.09.006_bib37","doi-asserted-by":"crossref","first-page":"574068","DOI":"10.3389\/fphar.2020.574068","article-title":"Simvastatin suppresses human breast cancer cell invasion by decreasing the expression of pituitary tumor-transforming Gene 1","volume":"11","author":"Yin","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2021.09.006_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/cas.14225","article-title":"Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells","volume":"111","author":"Okubo","year":"2020","journal-title":"Cancer Sci"},{"key":"10.1016\/j.apsb.2021.09.006_bib39","first-page":"2478","article-title":"Atorvastatin exhibits anti-tumorigenic and anti-metastatic effects in ovarian cancer in\u00a0vitro","volume":"7","author":"Jones","year":"2017","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib40","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1111\/jcmm.14879","article-title":"Lovastatin-mediated MCF-7 cancer cell death involves LKB1\u2013AMPK\u2013p38MAPK\u2013p53\u2013survivin signalling cascade","volume":"24","author":"Huang","year":"2020","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.apsb.2021.09.006_bib41","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.ccell.2015.08.012","article-title":"Dual targeting of the autophagic regulatory circuitry in gliomas with repurposed drugs elicits cell-lethal autophagy and therapeutic benefit","volume":"28","author":"Shchors","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2021.09.006_bib42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.15252\/emmm.201505421","article-title":"The anti-hypertensive drug prazosin inhibits glioblastoma growth via the PKCdelta-dependent inhibition of the AKT pathway","volume":"8","author":"Assad Kahn","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.apsb.2021.09.006_bib43","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.gastro.2019.05.057","article-title":"Intestinal PPARalpha protects against colon carcinogenesis via regulation of methyltransferases DNMT1 and PRMT6","volume":"157","author":"Luo","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.006_bib44","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/imm.13160","article-title":"Dissecting pharmacological effects of chloroquine in cancer treatment: interference with inflammatory signaling pathways","volume":"159","author":"Varisli","year":"2020","journal-title":"Immunology"},{"key":"10.1016\/j.apsb.2021.09.006_bib45","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/s10495-015-1132-2","article-title":"Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells","volume":"20","author":"Qin","year":"2015","journal-title":"Apoptosis"},{"key":"10.1016\/j.apsb.2021.09.006_bib46","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/med.21446","article-title":"Artemisinin as an anticancer drug: recent advances in target profiling and mechanisms of action","volume":"37","author":"Wong","year":"2017","journal-title":"Med Res Rev"},{"key":"10.1016\/j.apsb.2021.09.006_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.semcancer.2019.09.022","article-title":"Repurposing of drugs as STAT3 inhibitors for cancer therapy","volume":"68","author":"Thilakasiri","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.semcancer.2019.09.021","article-title":"Repurposing quinacrine for treatment-refractory cancer","volume":"68","author":"Oien","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib49","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.4161\/auto.26506","article-title":"The antimalarial amodiaquine causes autophagic-lysosomal and proliferative blockade sensitizing human melanoma cells to starvation- and chemotherapy-induced cell death","volume":"9","author":"Qiao","year":"2013","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.09.006_bib50","doi-asserted-by":"crossref","first-page":"112957","DOI":"10.1016\/j.ejmech.2020.112957","article-title":"Chemistry, biosynthesis and biological activity of terpenoids and meroterpenoids in bacteria and fungi isolated from different marine habitats","volume":"210","author":"Gozari","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.006_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1634\/theoncologist.2012-314","article-title":"Repurposing itraconazole as a treatment for advanced prostate cancer: a noncomparative randomized phase II trial in men with metastatic castration-resistant prostate cancer","volume":"18","author":"Antonarakis","year":"2013","journal-title":"Oncol"},{"key":"10.1016\/j.apsb.2021.09.006_bib52","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4161\/auto.28912","article-title":"Itraconazole suppresses the growth of glioblastoma through induction of autophagy: involvement of abnormal cholesterol trafficking","volume":"10","author":"Liu","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2021.09.006_bib53","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1158\/1078-0432.CCR-18-1854","article-title":"Ketoconazole and posaconazole selectively target HK2-expressing glioblastoma cells","volume":"25","author":"Agnihotri","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib54","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2018.09.022","article-title":"Ketoconazole exacerbates mitophagy to induce apoptosis by downregulating cyclooxygenase-2 in hepatocellular carcinoma","volume":"70","author":"Chen","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.09.006_bib55","doi-asserted-by":"crossref","first-page":"830","DOI":"10.7150\/thno.22012","article-title":"Drug repurposing screening identifies tioconazole as an ATG4 inhibitor that suppresses autophagy and sensitizes cancer cells to chemotherapy","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2021.09.006_bib56","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1158\/0008-5472.CAN-13-3540","article-title":"Novel drug candidates for the treatment of metastatic colorectal cancer through global inverse gene-expression profiling","volume":"74","author":"van Noort","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib57","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3390\/ijms20020268","article-title":"Ciprofloxacin enhances the chemosensitivity of cancer cells to ABCB1 substrates","volume":"20","author":"Gupta","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2021.09.006_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3892\/or.2020.7602","article-title":"Ciprofloxacin promotes polarization of CD86+CD206\u2013 macrophages to suppress liver cancer","volume":"44","author":"Fan","year":"2020","journal-title":"Oncol Rep"},{"key":"10.1016\/j.apsb.2021.09.006_bib59","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1016\/S1473-3099(18)30110-5","article-title":"Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies","volume":"18","author":"Tiberi","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.apsb.2021.09.006_bib60","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.18632\/aging.100983","article-title":"Bedaquiline, an FDA-approved antibiotic, inhibits mitochondrial function and potently blocks the proliferative expansion of stem-like cancer cells (CSCs)","volume":"8","author":"Fiorillo","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.apsb.2021.09.006_bib61","article-title":"Mitochondrial mutations and mitoepigenetics: focus on regulation of oxidative stress-induced responses in breast cancers","author":"Chen","year":"2020","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib62","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.3390\/ijms20143577","article-title":"Biological functions and molecular mechanisms of antibiotic tigecycline in the treatment of cancers","volume":"20","author":"Dong","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2021.09.006_bib63","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1111\/bph.12800","article-title":"Identification of an old antibiotic clofoctol as a novel activator of unfolded protein response pathways and an inhibitor of prostate cancer","volume":"171","author":"Wang","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2021.09.006_bib64","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1476-4598-8-26","article-title":"Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells","volume":"8","author":"Kumar","year":"2009","journal-title":"Mol Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib65","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ccell.2016.02.003","article-title":"Inhibiting drivers of non-mutational drug tolerance is a salvage strategy for targeted melanoma therapy","volume":"29","author":"Smith","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2021.09.006_bib66","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/1078-0432.CCR-16-0024","article-title":"Everything old is new again: using nelfinavir to radiosensitize rectal cancer","volume":"22","author":"Meyn","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib67","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1158\/0008-5472.CAN-19-1167","article-title":"Recent advances targeting CCR5 for cancer and its role in immuno-oncology","volume":"79","author":"Jiao","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13058-018-0981-3","article-title":"Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis","volume":"20","author":"Jin","year":"2018","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib69","doi-asserted-by":"crossref","first-page":"9492","DOI":"10.1021\/jm300667v","article-title":"Repositioning HIV-1 integrase inhibitors for cancer therapeutics: 1,6-naphthyridine-7-carboxamide as a promising scaffold with drug-like properties","volume":"55","author":"Zeng","year":"2012","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.006_bib70","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nrc.2016.4","article-title":"Aspirin and colorectal cancer: the promise of precision chemoprevention","volume":"16","author":"Drew","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib71","article-title":"Study finds possible role for aspirin as treatment for colon cancer","volume":"344","author":"Kmietowicz","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2021.09.006_bib72","doi-asserted-by":"crossref","first-page":"931","DOI":"10.3390\/cancers11070931","article-title":"Synergy between auranofin and celecoxib against colon cancer in\u00a0vitro and in\u00a0vivo through a novel redox-mediated mechanism","volume":"11","author":"Han","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2021.09.006_bib73","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41392-020-00253-0","article-title":"Auranofin mitigates systemic iron overload and induces ferroptosis via distinct mechanisms","volume":"5","author":"Yang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2021.09.006_bib74","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.pan.2018.02.006","article-title":"Celecoxib suppresses proliferation and metastasis of pancreatic cancer cells by down-regulating STAT3\/NF-\u03baB and L1CAM activities","volume":"18","author":"Zuo","year":"2018","journal-title":"Pancreatology"},{"key":"10.1016\/j.apsb.2021.09.006_bib75","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1159\/000430326","article-title":"Celecoxib and ibuprofen restore the ATP content and the gluconeogenesis activity in the liver of walker-256 tumor-bearing rats","volume":"36","author":"de Souza","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.apsb.2021.09.006_bib76","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3390\/cancers12020523","article-title":"Antiparkinson drug benztropine suppresses tumor growth, circulating tumor cells, and metastasis by acting on SLC6A3\/DAT and reducing STAT3","volume":"12","author":"Sogawa","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2021.09.006_bib77","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13046-017-0530-4","article-title":"Benserazide, a dopadecarboxylase inhibitor, suppresses tumor growth by targeting hexokinase 2","volume":"36","author":"Li","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib78","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.intimp.2012.11.018","article-title":"Diverse age-related effects of Bacopa monnieri and donepezil in vitro on cytokine production, antioxidant enzyme activities, and intracellular targets in splenocytes of F344 male rats","volume":"15","author":"Priyanka","year":"2013","journal-title":"Int Immunopharm"},{"key":"10.1016\/j.apsb.2021.09.006_bib79","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40263-019-00618-2","article-title":"Expanding role of NMDA receptor antagonists in the management of pain","volume":"33","author":"Kreutzwiser","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.apsb.2021.09.006_bib80","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2016.08.028","article-title":"Glutamate release inhibitor, riluzole, inhibited proliferation of human hepatocellular carcinoma cells by elevated ROS production","volume":"382","author":"Seol","year":"2016","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2021.09.006_bib81","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13046-020-1534-z","article-title":"Repurposing chlorpromazine in the treatment of glioblastoma multiforme: analysis of literature and forthcoming steps","volume":"39","author":"Abbruzzese","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib82","first-page":"459","article-title":"Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases","volume":"9","author":"Xu","year":"2019","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib83","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/cancers11091310","article-title":"Repurposing penfluridol in combination with temozolomide for the treatment of glioblastoma","volume":"11","author":"Kim","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2021.09.006_bib84","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/ijc.24813","article-title":"Cytotoxic effects of antipsychotic drugs implicate cholesterol homeostasis as a novel chemotherapeutic target","volume":"126","author":"Wiklund","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib85","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.canlet.2017.01.042","article-title":"A chemical genomics approach to drug reprofiling in oncology: antipsychotic drug risperidone as a potential adenocarcinoma treatment","volume":"393","author":"Dilly","year":"2017","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2021.09.006_bib86","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cpt.597","article-title":"Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update","volume":"102","author":"Hicks","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2021.09.006_bib87","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1158\/2159-8290.CD-13-0790","article-title":"Teaching an old dog new tricks: drug repositioning in small cell lung cancer","volume":"3","author":"Wang","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2021.09.006_bib88","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/2159-8290.CD-13-0183","article-title":"A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors","volume":"3","author":"Jahchan","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.apsb.2021.09.006_bib89","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/s41419-019-2172-2","article-title":"All-trans retinoic acid enhances, and a pan-RAR antagonist counteracts, the stem cell promoting activity of EVI1 in acute myeloid leukemia","volume":"10","author":"Nguyen","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.09.006_bib90","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.canlet.2018.01.058","article-title":"Repurposing psychiatric drugs as anti-cancer agents","volume":"419","author":"Huang","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.apsb.2021.09.006_bib91","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12402","article-title":"Fluoxetine induces autophagic cell death via eEF2K\u2013AMPK\u2013mTOR\u2013ULK complex axis in triple negative breast cancer","volume":"51","author":"Sun","year":"2018","journal-title":"Cell Prolif"},{"key":"10.1016\/j.apsb.2021.09.006_bib92","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.2174\/0929867327666200907141452","article-title":"Antidepressants and antipsychotic agents as repurposable oncological drug candidates","volume":"28","author":"Antoszczak","year":"2021","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.apsb.2021.09.006_bib93","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3390\/cancers11010064","article-title":"Paroxetine induces apoptosis of human breast cancer MCF-7 cells through Ca2+-and p38 MAP kinase-dependent ROS generation","volume":"11","author":"Cho","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2021.09.006_bib94","first-page":"2043","article-title":"Repurposing antidepressant sertraline as a pharmacological drug to target prostate cancer stem cells: dual activation of apoptosis and autophagy signaling by deregulating redox balance","volume":"10","author":"Chinnapaka","year":"2020","journal-title":"Am J Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib95","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/s41419-018-1018-7","article-title":"Proscillaridin A exerts anti-tumor effects through GSK3beta activation and alteration of microtubule dynamics in glioblastoma","volume":"9","author":"Berges","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.09.006_bib96","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3390\/ijms21072649","article-title":"Combination of arsenic trioxide and valproic acid efficiently inhibits growth of lung cancer cells via G2\/M-phase arrest and apoptotic cell death","volume":"21","author":"Park","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2021.09.006_bib97","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.addr.2018.08.012","article-title":"The potential to treat lung cancer via inhalation of repurposed drugs","volume":"133","author":"Lee","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.apsb.2021.09.006_bib98","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7175067","article-title":"Pioglitazone effect on glioma stem cell lines: really a promising drug therapy for glioblastoma?.","volume":"2016","author":"Cilibrasi","year":"2016","journal-title":"PPAR Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11010-010-0637-9","article-title":"Peroxisome proliferator-activated receptor gamma agonist pioglitazone inhibits beta-catenin-mediated glioma cell growth and invasion","volume":"349","author":"Wan","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.apsb.2021.09.006_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccell.2018.12.002","article-title":"Gain fat-lose metastasis: converting invasive breast cancer cells into adipocytes inhibits cancer metastasis","volume":"35","author":"Ishay-Ronen","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.apsb.2021.09.006_bib101","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13046-017-0498-0","article-title":"Buformin inhibits the stemness of ErbB-2-overexpressing breast cancer cells and premalignant mammary tissues of MMTV-ErbB-2 transgenic mice","volume":"36","author":"Parris","year":"2017","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib102","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.3390\/cancers11091284","article-title":"Mebendazole as a candidate for drug repurposing in oncology: an extensive review of current literature","volume":"11","author":"Guerini","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2021.09.006_bib103","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.redox.2016.09.013","article-title":"Albendazole as a promising molecule for tumor control","volume":"10","author":"Castro","year":"2016","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib104","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1039\/C5MB00466G","article-title":"Systems biology-based discovery of a potential Atg4B agonist (flubendazole) that induces autophagy in breast cancer","volume":"11","author":"Zhang","year":"2015","journal-title":"Mol Biosyst"},{"key":"10.1016\/j.apsb.2021.09.006_bib105","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1053\/j.gastro.2017.02.039","article-title":"Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells in\u00a0vitro and in mice by inhibiting cell division cycle 37 signaling","volume":"152","author":"Chen","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.09.006_bib106","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.1038\/s41388-018-0340-y","article-title":"Activation of STAT3 and Bcl-2 and reduction of reactive oxygen species (ROS) promote radioresistance in breast cancer and overcome of radioresistance with niclosamide","volume":"37","author":"Lu","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2021.09.006_bib107","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s40425-019-0733-7","article-title":"Niclosamide, an antihelmintic drug, enhances efficacy of PD-1\/PD-L1 immune checkpoint blockade in non-small cell lung cancer","volume":"7","author":"Luo","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib108","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.semcancer.2019.10.018","article-title":"Current state and future perspective of drug repurposing in malignant glioma","volume":"68","author":"Siegelin","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib109","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3390\/cancers12010106","article-title":"Repurposing antibacterial AM404 as a potential anticancer drug for targeting colorectal cancer stem-like cells","volume":"12","author":"Ahmed","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2021.09.006_bib110","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201701476","article-title":"Drug repositioning to alleviate systemic inflammatory response syndrome caused by Gram-negative bacterial outer membrane vesicles","volume":"7","author":"Kim","year":"2018","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.apsb.2021.09.006_bib111","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1021\/jm401144z","article-title":"Drug design targeting protein-protein interactions (PPIs) using multiple ligand simultaneous docking (MLSD) and drug repositioning: discovery of raloxifene and bazedoxifene as novel inhibitors of IL-6\/GP130 interface","volume":"57","author":"Li","year":"2014","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.09.006_bib112","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ebiom.2016.06.013","article-title":"Repurposing cationic amphiphilic antihistamines for cancer treatment","volume":"9","author":"Ellegaard","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2021.09.006_bib113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001379","article-title":"Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agent","volume":"10","author":"Cha","year":"2012","journal-title":"PLoS Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib114","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/biom11050706","article-title":"Repositioning azelnidipine as a dual inhibitor targeting CD47\/SIRPalpha and TIGIT\/PVR pathways for cancer immuno-therapy","volume":"11","author":"Zhou","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2021.09.006_bib115","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s12967-016-1031-5","article-title":"Repurposing of approved cardiovascular drugs","volume":"14","author":"Ishida","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.apsb.2021.09.006_bib116","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamaoncol.2019.0892","article-title":"Yeap BY, et\u00a0al. Total neoadjuvant therapy with FOLFIRINOX in combination with losartan followed by chemoradiotherapy for locally advanced pancreatic cancer: a phase 2 clinical trial","volume":"5","author":"Murphy","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.apsb.2021.09.006_bib117","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1158\/1940-6207.CAPR-17-0132","article-title":"Topically applied carvedilol attenuates solar ultraviolet radiation induced skin carcinogenesis","volume":"10","author":"Huang","year":"2017","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.apsb.2021.09.006_bib118","doi-asserted-by":"crossref","first-page":"12435","DOI":"10.1073\/pnas.1920310117","article-title":"The beta-arrestin-biased beta-adrenergic receptor blocker carvedilol enhances skeletal muscle contractility","volume":"117","author":"Kim","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2021.09.006_bib119","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3892\/ijo_00000563","article-title":"Carvedilol in glioma treatment alone and with imatinib in\u00a0vitro","volume":"36","author":"Erguven","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.apsb.2021.09.006_bib120","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.jacc.2019.03.495","article-title":"Randomized trial of lisinopril versus carvedilol to prevent trastuzumab cardiotoxicity in patients with breast cancer","volume":"73","author":"Guglin","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.apsb.2021.09.006_bib121","doi-asserted-by":"crossref","first-page":"104587","DOI":"10.1016\/j.phrs.2019.104587","article-title":"Beta-blockers: their new life from hypertension to cancer and migraine","volume":"151","author":"Fumagalli","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib122","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/ijc.30520","article-title":"Cardiac glycosides and breast cancer risk: a systematic review and meta-analysis of observational studies","volume":"140","author":"Karasneh","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib123","doi-asserted-by":"crossref","first-page":"17009","DOI":"10.1038\/cddiscovery.2017.9","article-title":"Antitumor effects of naturally occurring cardiac glycosides convallatoxin and peruvoside on human ER+ and triple-negative breast cancers","volume":"3","author":"Kaushik","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.09.006_bib124","doi-asserted-by":"crossref","first-page":"13201","DOI":"10.2147\/OTT.S283033","article-title":"Comparative study of lipophilic statin activity in 2D and 3D in\u00a0vitro models of human breast cancer cell lines MDA-MB-231 and MCF-7","volume":"13","author":"Bytautaite","year":"2020","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.apsb.2021.09.006_bib125","doi-asserted-by":"crossref","first-page":"7047","DOI":"10.1038\/s41598-018-25526-1","article-title":"All-trans-retinoic acid activates the pro-invasive Src-YAP-interleukin 6 axis in triple-negative MDA-MB-231 breast cancer cells while cerivastatin reverses this action","volume":"8","author":"Mezquita","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2021.09.006_bib126","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/ijc.30526","article-title":"Effects of statins on cancer mortality and progression: a systematic review and meta-analysis of 95 cohorts including 1,111,407 individuals","volume":"140","author":"Mei","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib127","doi-asserted-by":"crossref","first-page":"108675","DOI":"10.1016\/j.abb.2020.108675","article-title":"Efflux mechanism and pathway of verapamil pumping by human P-glycoprotein","volume":"696","author":"Wang","year":"2020","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.apsb.2021.09.006_bib128","doi-asserted-by":"crossref","first-page":"5720","DOI":"10.1158\/1078-0432.CCR-20-1569","article-title":"Sildenafil potentiates the therapeutic efficacy of docetaxel in advanced prostate cancer by stimulating NO\u2013cGMP signaling","volume":"26","author":"Muniyan","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib129","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1158\/1078-0432.CCR-18-2204","article-title":"Autophagy inhibition to augment mTOR inhibition: a phase I\/II trial of everolimus and hydroxychloroquine in patients with previously treated renal cell carcinoma","volume":"25","author":"Haas","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.apsb.2021.09.006_bib130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","article-title":"From ancient herb to modern drug: Artemisia annua and artemisinin for cancer therapy","volume":"46","author":"Efferth","year":"2017","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib131","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/j.drudis.2021.02.004","article-title":"A new horizon for the old antibacterial drug clofoctol","volume":"26","author":"Bailly","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.apsb.2021.09.006_bib132","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1172\/JCI124979","article-title":"The antibiotic clofoctol suppresses glioma stem cell proliferation by activating KLF13","volume":"129","author":"Hu","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.apsb.2021.09.006_bib133","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ejca.2020.09.017","article-title":"Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma","volume":"140","author":"Rauschenbach","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib134","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.3389\/fonc.2020.01693","article-title":"Efavirenz and lopinavir\/ritonavir alter cell cycle regulation in lung cancer","volume":"10","author":"Marima","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.apsb.2021.09.006_bib135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/djw251","article-title":"Nonsteroidal anti-inflammatory drugs and endometrial carcinoma mortality and recurrence","volume":"109","author":"Brasky","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.apsb.2021.09.006_bib136","doi-asserted-by":"crossref","first-page":"a028035","DOI":"10.1101\/cshperspect.a028035","article-title":"Pathology of neurodegenerative diseases","volume":"9","author":"Dugger","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.apsb.2021.09.006_bib137","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40478-019-0657-y","article-title":"Preventive action of benztropine on platinum-induced peripheral neuropathies and tumor growth","volume":"7","author":"Cerles","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.1016\/j.apsb.2021.09.006_bib138","doi-asserted-by":"crossref","first-page":"190","DOI":"10.4088\/JCP.15m10324","article-title":"High-dose citalopram and escitalopram and the risk of out-of-hospital death","volume":"78","author":"Ray","year":"2017","journal-title":"J Clin Psychiatr"},{"key":"10.1016\/j.apsb.2021.09.006_bib139","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/s41419-020-03065-w","article-title":"CB13, a novel PPARgamma ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer","volume":"11","author":"Kim","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2021.09.006_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/cells9010001","article-title":"Repaglinide silences the FOXO3\/Lumican axis and represses the associated metastatic potential of neuronal cancer cells","volume":"9","author":"Salcher","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2021.09.006_bib141","doi-asserted-by":"crossref","first-page":"8080","DOI":"10.7150\/thno.43473","article-title":"Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in triple-negative breast cancer","volume":"10","author":"Zhen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2021.09.006_bib142","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.bbcan.2019.04.005","article-title":"Drug repurposing in oncology: compounds, pathways, phenotypes and computational approaches for colorectal cancer","volume":"1871","author":"Nowak-Sliwinska","year":"2019","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.apsb.2021.09.006_bib143","doi-asserted-by":"crossref","first-page":"100713","DOI":"10.1016\/j.drup.2020.100713","article-title":"Repurposing old drugs to fight multidrug resistant cancers","volume":"52","author":"Dinic","year":"2020","journal-title":"Drug Resist Updates"},{"key":"10.1016\/j.apsb.2021.09.006_bib144","doi-asserted-by":"crossref","first-page":"3476","DOI":"10.1038\/s41467-019-10744-6","article-title":"A genome-wide positioning systems network algorithm for in silico drug repurposing","volume":"10","author":"Cheng","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.09.006_bib145","doi-asserted-by":"crossref","first-page":"10520","DOI":"10.1021\/acs.chemrev.8b00728","article-title":"Concepts of artificial intelligence for computer-assisted drug discovery","volume":"119","author":"Yang","year":"2019","journal-title":"Chem Rev"},{"key":"10.1016\/j.apsb.2021.09.006_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.09.013","article-title":"Crispr-mediated programmable 3D genome positioning and nuclear organization","volume":"175","author":"Wang","year":"2018","journal-title":"Cell"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521003488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:56:12Z","timestamp":1761929772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521003488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":146,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2211383521003488"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.09.006","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing non-oncology small-molecule drugs to improve cancer therapy: Current situation and future directions","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}